VYTRA
LIVE

Serial Number

98495156

Owner

EMx Biotech LLC

Attorney

Amit Kulkarni

First Use Date

May 25, 2023

Filing Date

Apr 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VYTRA Trademark

Serial Number: 98495156

VYTRA is a trademark filed by EMx Biotech LLC on April 11, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

EMx Biotech LLC (2 trademarks)

1633 Waterston Ave., Apt. C
Austin, TX 78703

Entity Type: 16

Trademark Details

Filing Date

April 11, 2024

Registration Date

Not Registered

First Use Anywhere

May 25, 2023

First Use in Commerce

May 25, 2023

Published for Opposition

January 28, 2025

Goods & Services

Downloadable Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Pressure measuring apparatus; Recorded Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Recorded Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the heart; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; Software as a Medical Device (SaMD), recorded, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), recorded, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), recorded, for use as a medical instrument for vital sign monitoring

Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing suspected heart attacks; Medical apparatus for monitoring blood glucose levels; Medical apparatus for monitoring vital signs of patients; Medical apparatus for preventing or reversing heart failure; Medical apparatus for the treatment of respiratory conditions; Medical apparatus for use in treating abnormal vital signs; Medical apparatus, namely, fetal and maternal vital sign and physical distress monitors; Medical apparatus, namely, respiratory equipment and monitors therefor; Medical device used for the acquisition of physiological data for polysomnography; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of recorded software for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for treating congestive heart failure; Medical devices for use in diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs with integrated recorded operating system software, sold as a unit; Medical devices for use in treating abnormal vital signs; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse generators for vital sign monitoring; Medical and surgical apparatus and instruments for use in vital sign monitoring procedures; Medical diagnostic apparatus for testing vital signs; Medical diagnostic apparatus for testing vital signs incorporating recorded software for vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring; Medical imaging apparatus for vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring incorporating recorded software for vital sign monitoring; Medical imaging apparatus with embedded operating system software; Medical imaging devices for vital sign monitoring; Blood pressure and diabetic diagnostic medical devices; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Diagnostic apparatus for medical purposes used in medical laboratories for testing vital signs; Manometers for medical purposes being arterial blood pressure measuring apparatus; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Surgical and medical apparatus and instruments for use in general surgery; Surgical and medical apparatus and instruments for use in vital sign monitoring during surgery; Ultrasound apparatus for medical purposes; Ultrasound apparatus for medical use

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 1, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 26, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 26, 2026 AITU
USE AMENDMENT FILED
Sep 25, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 25, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 25, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2024 CNEA
ASSIGNED TO EXAMINER
Oct 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2024 NWOS
NEW APPLICATION ENTERED
Apr 11, 2024 NWAP